Wed, Aug 27, 2014, 6:59 AM EDT - U.S. Markets open in 2 hrs 31 mins


% | $
Quotes you view appear here for quick access.

Clean Energy Fuels Corp. Message Board

tommccauley31 55 posts  |  Last Activity: Aug 25, 2014 10:22 AM Member since: Dec 3, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • tommccauley31 by tommccauley31 Aug 25, 2014 10:22 AM Flag

    Last weeks Form 4's showed board member
    Aylesworth sold 1600 shares to acquire
    5000 option shares at $4.60.
    The former chairman has been acquiring
    swap shares over the last 2 years.
    There are many reasons to sell, but only
    one reason to buy!

  • tommccauley31 by tommccauley31 Aug 25, 2014 10:12 AM Flag

    Form 4's filed last week show 2 insiders
    purchasing a nominal number of shares.
    Frank Russomanno purchased 3476 at $3.78,
    and Phil Soran 4,600 at $3.78.
    There are a lot of reason insiders sell,
    but only one reason they "buy".

  • Reply to

    Barry's election

    by halbeck99 Aug 22, 2014 12:08 PM
    tommccauley31 tommccauley31 Aug 22, 2014 1:00 PM Flag

    Good infomation, as usual Halbeck!
    Explains why Barry isn't looking to another election.
    He's as popular as a root canal.

  • tommccauley31 by tommccauley31 Aug 22, 2014 12:18 PM Flag

    Last summer HSKA announced the sale of non core
    assets (Bovine and feline vaccines) to Eli Lilly's/ Elanco
    Animal Health. Heska produced these vaccines at the
    Diamond Facility in Des Moines,IA. As part of the sale
    Heska agreed to continue manufacturing the vaccines
    at Diamond as a subcontract manufacturer. Elanco could
    elect to change the agreement by a buyout of the 10 yr contract.
    I believe this move was Heska's best option to exit the
    OVP business. By partnering with Eli Lilly, Heska gives
    Elanco a honeymoon period to do due diligence on the
    operations at Diamond. I would be a bit surprised to see
    an eventual sale of the Iowa plant and equipment to Elanco.

  • Reply to

    Our 30 communities we own are worth a bundle

    by msears99 Aug 20, 2014 9:38 PM
    tommccauley31 tommccauley31 Aug 21, 2014 1:04 PM Flag

    Sears, With or without restated financials, you would
    think VTR, and others can do back of envelope math.
    It would be nice too see Ventas make an unsolicited
    offer for FVE. Many felt VTR stole the deal you mentioned.

  • tommccauley31 by tommccauley31 Aug 21, 2014 9:59 AM Flag

    If Portnoy learned anything by his dismissal
    from CWH??? Shareholders have his number.
    Can we blame the weasel for squirming a bit?

  • tommccauley31 by tommccauley31 Aug 21, 2014 9:55 AM Flag

    Heska is finally starting to show growth and
    still trades at a dramatic discount to peers.
    IDXX trades at 15x book, while ABAX is at 5x.
    Little HSKA trades at 1.5 x book value, and has
    a lot of room for multiple expansion.
    I expect CEO Wilson to continue to expand on
    revenue growth, and profitability.
    Wilson IMO executed the biggest coup of his
    career parlaying his little company Cuattro into
    a takeover of Heska. Who acquired who?
    Wilson now has double the shares of any
    other insider including the founder Grieve.
    He has no emotional ties to Heska, and is
    in a position to dispose of non producing assets.
    A sale of OVP facilities and land could add $4
    per share in cash.
    I expect to see Heska trading at $20 and above
    by year end. I wouldn't even be a bit surprised
    to see Heska acquired in the next year.

  • Reply to

    Is Heska worth it?

    by tommccauley31 Aug 20, 2014 12:19 PM
    tommccauley31 tommccauley31 Aug 20, 2014 4:06 PM Flag

    Db, Many years ago I had a girlfriend that had a
    perfect pair. I used to call her "double nickels".
    I will defer to your expertise if you're an accountant?
    However, I used to have rental properties which I
    would elect to depreciate on a 10-20 yr schedule.
    Looking at Heskas balance sheet they show equipment
    as a depreciable balance sheet item and it has grown
    from $4M to $9M in the past 2 years. I assume they
    have added new equipment but this does not reflect the
    value of the underlying Real estate in Iowa. Last year HSKA
    announced selling the proprietary patents and rights
    to several vaccines, and entered into a 10yr agreement
    to continue to produce the afore-mentioned vaccines.
    It is my contention that the manufacturing business was
    never in Heskas baliwick and should be spun off.
    I see the OVP as a dying entity. Heska can easily subcontract
    to have the heartworm preventive mfg'd for resale.

  • Reply to

    Is Heska worth it?

    by tommccauley31 Aug 20, 2014 12:19 PM
    tommccauley31 tommccauley31 Aug 20, 2014 12:45 PM Flag

    dbldeal, Heska purchased the Iowa land and Diamond
    nearly 20yrs ago for approx $12M plus assumed debt.
    The company has upgraded the facility over the years
    with production and packaging equipment to be FDA
    compliant. This is the only real estate Heska owns.
    HSKA leases their headquarters in Loveland on a triple
    net lease arrangement. I see no place on Heska's balance
    sheet where they give a value to this property. Do you?

  • Reply to

    Long term bargain stock.............

    by arobin2012 Jul 29, 2014 1:42 AM
    tommccauley31 tommccauley31 Aug 20, 2014 12:34 PM Flag

    There are several catalysts that could give
    shareholders a positive surprize.
    CVS pharmacy has been pilot testing Abaxis
    POC analyzer for several months for use in
    their in store clinics. The breakthrough of
    a large order of the analyzers would bring with
    it a steady recurring reagent stream.
    Abbott is also partnering with Abaxis to
    place the POC analyzers. The large marketing
    reach of Abbott through their existing salesforce
    should increase sales.
    Up to now veterinary sales has eclipsed human
    diagnostic equipment sales by a 80-20% margin.
    That should change with placement of the Piccolo
    in acute care clinics, pharmacy clinics, and other
    alternative hospital settings.

  • tommccauley31 by tommccauley31 Aug 20, 2014 12:19 PM Flag

    Heska has shown solid momentum since
    newcomer Wilson took charge.
    For the first time sine 2007 the company
    is on track to show revenue growth.
    What show the faithful expect over the next
    few quarters?
    Heska has a history of seasonality. It performs
    better in the last quarter of the year, and first
    quarter than it does in spring and summer.
    What is different this year is the new product ramps
    that are boosting equipment placements.
    (the handheld analyzer is an example)
    The "RESET" marketing program has been well
    received by customers. And with every hardware
    placement, comes a steady stream of reagent sales.
    Operating margins are improving. Heska is finally
    able to show profits that can be sheltered using
    the NOL's (operating loss carry forwards)
    The imaging "Cuattro" division is growing sales
    and offers ccustomers a compelling reason to
    bundle with HSKA.
    Wilson has brought an upbeat attitude to employees.
    Happy employees are vested in the companies success.
    Heska also has some undervalued assets I expect will
    be disposed. The OVP division is not an essential core
    business. Diamond Animal Health exists only to mfg and
    distribute vaccines, and preventives, for third parties.
    The Carlylse, and Des Moines plant and real estate
    acreage is worth $15-$20M by my estimate. Heska has
    depreciated these assets to zero. A sale of this property
    would add $5/share IMO.
    Wilson has many options and has only begun to unlock
    the value in Heska. There are many reasons to be bullish
    going forward. Buy the dips.

  • Reply to

    Kicking the can down the road:

    by tommccauley31 Aug 19, 2014 12:07 PM
    tommccauley31 tommccauley31 Aug 20, 2014 11:54 AM Flag

    WD4, I like your astute observations.
    I don't put anything past Porknoy after
    the backdoor deal he did with SIR to GOV.
    However, There is no way shareholders
    would vote positively for a take private deal
    without a substantial premium. A lower
    than book value bid would invite competing
    offers from others.
    SNH doesn't have enough juice to veto
    a competitors offer, and would be faced with
    getting into the mix to protect their own interests.

  • tommccauley31 by tommccauley31 Aug 20, 2014 11:44 AM Flag

    Heska has some intermediate weakness following
    a positive earnings report and forecast.
    If you missed the boat earlier? This is a good time
    to avg into HSKA.

  • tommccauley31 by tommccauley31 Aug 19, 2014 12:07 PM Flag

    As I suggested a week ago, another shareholder
    meeting postponed and continued further delay
    in filing SEC required reports.
    The company now states for the 3rd time, results
    from 2013 and 2014 are in process and will be
    forth coming? What about honest communication
    with share holders? When will that ever be forth coming?
    No one has received a proxy statement. FVE knew
    weeks ago that the August scheduled meeting would be
    postponed and confirmed by not mailing proxy info.
    The disingenuous attitude of Portney certainly doesn't
    make for building trust and credibility.
    Our best hope for disposing this BOD and RMR
    is to have SNH come to their senses and realize
    that a bigger REIT like Vestas is salivating over
    this disfunctional situation. A hostile bid for
    FVE would likely be received positively by shareholders.
    Five could conceivably be had at a discount to NAV
    just to spite the present management.

  • Reply to

    Looks like there is no stock for sale

    by rbrentbyrne Aug 18, 2014 1:10 PM
    tommccauley31 tommccauley31 Aug 19, 2014 11:06 AM Flag

    Rb, Having been on board since the depths of Dec 2011
    when SRT dipped as low as $1.55. I see no compelling
    reason to sell, and like you, share a strong conviction the
    best lies ahead for Startek.
    You have to like the progress Chad and his team have
    made in transforming the company. It is also positive that
    insiders continue to elect to accumulate share.
    Over 32% of the company is owned by insiders.
    These parties, as well as, institutions have strong conviction.
    SRT has always been a low float, low volume, equity.
    I expect if one waits on results of the next couple quarters,
    they will be chasing SRT.

  • I've been buying FVE hand over fist from $5 down.
    These low life sluggo's have to worry that they do
    not control enough of the float to deter a hostile offer.
    If Ventas or HCN offers me $6 for my shares, i'm a
    happy camper. Any operator is better than one who
    asks shareholders to bend over, and like it.
    Portnoy's intransnagense invites his own demise.

  • Reply to

    We should trade at 2x book like NCT

    by msears99 Aug 15, 2014 11:14 PM
    tommccauley31 tommccauley31 Aug 18, 2014 11:10 AM Flag

    I agree 100%. And while we're ready too depose Mackey,
    how about adding CFO Hoaglund to the slash pile.
    Hes the one in charge of the financial reports.
    Maybe the auditor Ernst & Young should also be fired.
    This company is full of self serving insiders that are
    tied to the hip with the Portney's. Its time to clean house.
    Every shareholder should be writing a letter to the
    auditor to inquire why this outfit cannot produce quarterly
    reports in a timely manner.

  • Reply to

    We should trade at 2x book like NCT

    by msears99 Aug 15, 2014 11:14 PM
    tommccauley31 tommccauley31 Aug 16, 2014 10:40 AM Flag

    4wd, I have to agree. The continued delay and self dealing
    by insiders calls for a shareholder lawsuit IMO.
    Everyone of these breaches of fiduciary duty only furthers
    the distrust of this gang led by Portnoy.
    It seems apparent without the consideration of an
    announcement. There will likely be no shareholders meeting
    in August, or update timetable for the restated earnings.

  • Reply to

    Healthcare sector is set to boom.

    by msears99 Aug 8, 2014 2:36 PM
    tommccauley31 tommccauley31 Aug 13, 2014 11:38 AM Flag

    I agree with you straight4wd. Senior livings growth
    will be in private pay. Not subsidized by Obama care.
    Sears was making general observations about the
    changes in healthcare brought about by the ACA.
    There are a lot of companies benefiting by the changes.
    What we need to seek with FVE is an activist investor,
    or a shareholder lawsuit that takes Portnoy and the board
    to task for breach of fidicuary duty, and self dealing.
    It doesn't appear we are going to see the belated financial
    restatements anytime soon. I also suspect the several times
    postponed shareholders meeting scheduled for Aug 27
    will be postponed again. These sluggos have no
    interest in creating shareholder value.

  • tommccauley31 by tommccauley31 Aug 13, 2014 10:46 AM Flag

    SRT disappointing earnings call
    is just a road bump. Despite sp
    trading down today, the conviction
    shareholders are holding tight.
    There was good news within the
    reported results. Revenues up on
    a year over yr basis, new accounts
    logged, and margins increasing in
    offshore call centers with the closure
    of Costa Rica operations.

10.18+0.33(+3.35%)Aug 26 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.